Newsletter Subject

Fewer than half of U.S. jails provide life-saving medications for opioid use disorder

From

nih.gov

Email Address

NIDA@updates.nida.nih.gov

Sent On

Tue, Sep 24, 2024 04:26 PM

Email Preheader Text

Fewer than half of U.S. jails provide life-saving medications for opioid use disorder A new look int

[] [View as webpage / Share](%2F%2Fcontent.govdelivery.com%2Faccounts%2FUSNIHNIDA%2Fbulletins%2F3b7cfc2/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/Q2YM5Lk3zWfMNYE03vz8sx0NuWHdidudUEqhMug37qM=372) [NIH/NIDA logo] NEWS [A young mother with her daughter sitting in the living room together and painting their nails.] Fewer than half of U.S. jails provide life-saving medications for opioid use disorder A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the nation offered any form of medication for opioid use disorder, and only 12.8% made these available to anyone with the disorder. With [two-thirds](%2F%2Fbjs.ojp.gov%2Fcontent%2Fpub%2Fpdf%2Fdudaspji0709.pdf/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/JVmHHVlBFZFZoXT_qNvlwgvBHoxAHbGCCyOTwm-1n5I=372) of people who are incarcerated in U.S. jails experiencing a substance use disorder – in many cases, an opioid use disorder – the failure to make these medications widely available in criminal justice settings represents a significant missed opportunity to provide life-saving treatments in an environment where people in need of care can be easily reached. [View the Press Release](%2F%2Fnida.nih.gov%2Fnews-events%2Fnews-releases%2F2024%2F09%2Ffewer-than-half-of-us-jails-provide-life-saving-medications-for-opioid-use-disorder/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/R0X0wicFFMUlLl0kkD5DFdxSqT8FYhfqNMhtxxmKk0M=372) Stay Connected [facebook](%2F%2Fwww.facebook.com%2FNIDANIH/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/vueOL393CzB64ozGinMgWqc4-muDAOyefIOh9wn56jQ=372)[X](%2F%2Fx.com%2FNIDAnews/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/u3y8OMqeRZ4qb_cHCialwf7s9TQh6EE9mi7YTkuPXW8=372)[linkedin](%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-national-institute-on-drug-abuse-nida/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/laXg3K2XYbDP8kPKW4Urx4FJ4HSwyzRmsFZd1cTkXF4=372)[youtube](%2F%2Fwww.youtube.com%2Fuser%2FNIDANIH/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/V2sXELiFvaNtunAq1BSxX7MQ_f4G-BNUpjct50IAbnQ=372) --------------------------------------------------------------- View topics of interest, update your subscriptions, modify your password or email address, alter frequency of bulletins, or stop subscriptions at any time on your [Subscriber Preferences Page](%2F%2Fpublic.govdelivery.com%2Faccounts%2FUSNIHNIDA%2Fsubscriber%2Fnew%3Fpreferences=true/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/ZXuVLVKJqiZpfpKnbRkzn9eb7vigyyheREsLQuOeCwQ=372). You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](%2F%2Fsubscriberhelp.govdelivery.com%2F/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/Ah0Hr1pH_Yf9_7E_8D2mHV4So2LqMePAHwsIxUrbRJY=372). This service is provided to you at no charge by [National Institute on Drug Abuse](%2F%2Fnida.nih.gov%2F/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/eJJNxhmp7eS4xoxc0nOfVh6e9v0zhgGY1MTqs8ZMWlQ=372). --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of National Institutes of Health: National Institute on Drug Abuse · 3WFN MSC 6024 · 16071 Industrial Dr ·Dock 11 · Gaithersburg, MD 20877 [GovDelivery logo](%2F%2Fsubscriberhelp.granicus.com%2F/1/0100019224db5210-746fcba2-22a3-4abc-9e3e-955f4c36519f-000000/t-G8UDt-7uAKQpGguPWkL5-G9XiD0jbt3duu4Eo_Fpo=372)

Marketing emails from nih.gov

View More
Sent On

02/10/2024

Sent On

25/09/2024

Sent On

03/09/2024

Sent On

29/08/2024

Sent On

15/08/2024

Sent On

29/07/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.